Natixis Advisors’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $14.9M | Buy |
188,363
+106,976
| +131% | +$9.09M | 0.02% | 622 |
|
|
2026
Q1 | $7.01M | Sell |
81,387
-838
| -1% | -$75.2K | 0.01% | 756 |
|
|
2025
Q4 | $7.18M | Sell |
82,225
-2,856
| -3% | -$217K | 0.01% | 724 |
|
|
2025
Q3 | $4.87M | Sell |
85,081
-76,417
| -47% | -$4.4M | 0.01% | 844 |
|
|
2025
Q2 | $9.53M | Sell |
161,498
-42,388
| -21% | -$2.74M | 0.02% | 666 |
|
|
2025
Q1 | $14.9M | Buy |
203,886
+4,107
| +2% | +$339K | 0.03% | 533 |
|
|
2024
Q4 | $16.5M | Sell |
199,779
-57,964
| -22% | -$4.57M | 0.03% | 500 |
|
|
2024
Q3 | $18.4M | Sell |
257,743
-1,769
| -0.7% | -$125K | 0.04% | 454 |
|
|
2024
Q2 | $17.8M | Buy |
259,512
+28,638
| +12% | +$1.71M | 0.04% | 418 |
|
|
2024
Q1 | $12.4M | Buy |
230,874
+80,760
| +54% | +$4.34M | 0.03% | 537 |
|
|
2023
Q4 | $8M | Buy |
150,114
+47,047
| +46% | +$2.29M | 0.02% | 623 |
|
|
2023
Q3 | $5.12M | Buy |
103,067
+79,698
| +341% | +$4.46M | 0.02% | 701 |
|
|
2023
Q2 | $1.39M | Buy |
23,369
+5,138
| +28% | +$293K | ﹤0.01% | 1070 |
|
|
2023
Q1 | $1.03M | Sell |
18,231
-14,366
| -44% | -$921K | ﹤0.01% | 1127 |
|
|
2022
Q4 | $2.42M | Buy |
32,597
+6,122
| +23% | +$417K | 0.01% | 882 |
|
|
2022
Q3 | $1.58M | Sell |
26,475
-73,039
| -73% | -$4.4M | 0.01% | 964 |
|
|
2022
Q2 | $5.59M | Sell |
99,514
-32,125
| -24% | -$2.11M | 0.02% | 616 |
|
|
2022
Q1 | $9.71M | Buy |
131,639
+51,376
| +64% | +$3.57M | 0.04% | 469 |
|
|
2021
Q4 | $5.79M | Sell |
80,263
-52,861
| -40% | -$3.84M | 0.02% | 619 |
|
|
2021
Q3 | $10.2M | Buy |
133,124
+108,073
| +431% | +$8.68M | 0.04% | 414 |
|
|
2021
Q2 | $1.94M | Buy |
25,051
+6,824
| +37% | +$485K | 0.01% | 918 |
|
|
2021
Q1 | $1.12M | Sell |
18,227
-435
| -2% | -$27.5K | 0.01% | 1030 |
|
|
2020
Q4 | $1.22M | Sell |
18,662
-733
| -4% | -$42.1K | 0.01% | 967 |
|
|
2020
Q3 | $960K | Buy |
+19,395
| New | +$1M | 0.01% | 956 |
|
|
2020
Q2 | – | Sell |
-42,404
| Closed | -$1.8M | – | 1173 |
|
|
2020
Q1 | $1.8M | Buy |
+42,404
| New | +$2.1M | 0.01% | 760 |
|
|
2018
Q2 | – | Sell |
-24,875
| Closed | -$1.24M | – | 1089 |
|
|
2018
Q1 | $1.24M | Buy |
24,875
+26
| +0.1% | +$1.22K | 0.01% | 873 |
|
|
2017
Q4 | $1.02M | Buy |
24,849
+781
| +3% | +$27.3K | 0.01% | 875 |
|
|
2017
Q3 | $715K | Buy |
24,068
+3,888
| +19% | +$119K | 0.01% | 933 |
|
|
2017
Q2 | $669K | Sell |
20,180
-547
| -3% | -$17.2K | 0.01% | 936 |
|
|
2017
Q1 | $614K | Buy |
20,727
+2,192
| +12% | +$59.8K | 0.01% | 944 |
|
|
2016
Q4 | $460K | Buy |
+18,535
| New | +$421K | 0.01% | 957 |
|
Other funds holding GMED
JT
SC
Natixis Advisors's GMED Position: Q2 2026 in Review
Natixis Advisors increased its Globus Medical (GMED) stake by 131% in Q2 2026, buying an estimated $9.09M and bringing the position to 188,363 shares worth $14.9M. The position accounts for 0.02% of the portfolio, ranked #622.
Natixis Advisors first reported a position in GMED in Q4 2016 and has held it in 31 quarters since. The position peaked at $18.4M in Q3 2024. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.
- Natixis Advisors held 188,363 shares of Globus Medical worth $14.9M as of Q2 2026.
- Natixis Advisors bought 106,976 Globus Medical shares in Q2 2026, an estimated $9.09M.
- Globus Medical made up 0.02% of Natixis Advisors's portfolio in Q2 2026, its #622 holding.
- Natixis Advisors first reported a position in Globus Medical in Q4 2016 and has held it in 31 quarters since.
- Natixis Advisors's Globus Medical position peaked at $18.4M in Q3 2024.
- 596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.
Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.